skip navigation

S M L Text size

Focus on Glaucoma

Program

National Eye Institute
40th Anniversary Symposia Series
Focus on Glaucoma
February 18th-19th, 2010
National Institutes of Health - Bethesda Campus

THURSDAY, FEBRUARY 18TH
Bldg 38A - Lister Hill Auditorium
2:30 - 3:00 pm Registration
3:00 - 3:05 pm WELCOME ADDRESS
Paul A. Sieving, M.D., Ph.D.
Director, National Eye Institute (NEI), NIH
Evening session Chairperson: Neeraj Agarwal, Ph.D.
Director, Glaucoma and Optic Neuropathies Program, Division of Extramural Research,
National Eye Institute (NEI), NIH, Bethesda, MD
3:05 - 3:35 pm Jeffrey Goldberg, M.D., Ph.D.
Assistant Professor of Ophthalmology
Bascom Palmer Eye Institute
University of Miami, FL
Intrinsic Control of Regeneration in Retinal Ganglion Cells
3:40 - 4:10 pm Larry Benowitz, Ph.D.
Professor of Surgery (Neuroscience)
Harvard Medical School, Boston, MA
Director, Laboratories for Neuroscience Research in Neurosurgery
Children’s Hospital Boston
Boston, MA
Oncomodulin With Other Agents Promotes Extensive Optic Nerve Regeneration
4:15 - 4:30 pm Coffee break
4:30 - 5:00 pm Stanislav Tomarev, Ph.D. & Tom Johnson
NEI, Laboratory of Molecular and Developmental Biology
Molecular Mechanisms of Glaucoma Section
Bethesda, MD
Myocilin as a Tool to Study Glaucoma Stem Cell Transplantation for Neuroprotection in Glaucoma
5:05 - 5:30 pm Reception
FRIDAY, FEBRUARY 19TH
Bldg 10 - Lipsett Amphitheatre
8:30 - 9:00 Registration & Coffee
9:00 - 9:05 WELCOME ADDRESS
Paul A. Sieving, M.D., Ph.D.
Director, NEI, NIH, Bethesda, MD
Morning Session Chairperson: Paul A. Sieving, M.D., Ph.D.
Director, NEI, NIH, Bethesda, MD
9:05 - 9:35 KEYNOTE ADDRESS
Paul Lichter, M.D.
F. Bruce Fralick Professor of Ophthalmology
Chair, Ophthalmology and Visual Sciences
Director, University of Michigan Kellogg Eye Center
Ann Arbor, MI
The Enigma of Glaucoma's Holy Grail: The Promise and Problems of Research
9:40 - 10:10 Fielding Hejtmancik, M.D., Ph.D.
NEI, Ophthalmic Genetics and Visual Function Branch
Chief, Ophthalmic Molecular Genetics Section
Bethesda, MD
Genetics of Primary Open-Angle Glaucoma in the Afro-Caribbean Population of Barbados
10:15 - 10:35 Coffee break
10:35 - 11:05 Janey L. Wiggs, M.D. Ph.D.
Assistant Professor of Ophthalmology
Harvard Medical School
Massachusetts Eye and Ear Infirmary
Boston, MA
The NEIGHBOR Consortium GWAS for POAG: Rationale, Study Design, and Clinical Variables
11.10 - 11:40 Jonathan L. Haines, Ph.D.
Director, The Center for Human Genetics Research
T.H. Morgan Professor of Human Genetics
Professor of Molecular Physiology & Biophysics
Chief, Division of Human Genomics
Vanderbilt University Medical School
Nashville TN
Moving Forward: GWAS and Beyond
11.45 - 12:15 Terry Gaasterland, Ph.D.
Professor of Computational Genomics
Director, Scripps Genome Center
Institute for Genomic Medicine
University of California San Diego
La Jolla, CA
GWAS by Targeted Genome-Wide Sequencing in Glaucoma: Challenges, Trade-Offs, and Benefits
12:20 - 1:20 Lunch break
Afternoon Session Chairperson: Stanislav Tomarev, Ph.D.
NEI, Laboratory of Molecular and Developmental Biology
Head, Molecular Mechanisms of Glaucoma Section
Bethesda, MD
1:20 - 1:50 Robert N. Weinreb, M.D.
Director, Hamilton Glaucoma Center
Distinguished Professor
Chief, Glaucoma Division
Vice Chair, Department of Ophthalmology, University of California San Diego
La Jolla, CA
Uveoscleral Outflow: Learning From the Past, Lessons for the Future
1.55 - 2.25 David W Sretavan, M.D., Ph.D.
Edward and Estelle Alexander Professor
Depts. Ophthalmology & Physiology
Vice-Chair, Ophthalmology
University of California San Francisco
San Francisco, CA
RGC Axonal Responses in Experimental Glaucoma
2:30 - 2:50 Coffee break
2:50 - 3:20 Simon W. M. John, Ph.D.
Investigator, Howard Hughes Medical Institute
Senior Staff Scientist
The Jackson Laboratory
Bar Harbor, ME
Insights to Glaucoma From Mouse Genetics
3:25 - 3:55 Tiansen Li, M.D.
NEI, Neurobiology-Neurodegeneration & Repair Laboratory
Chief, Retinal Cell Biology & Degeneration Section
Bethesda, MD
Lysyl Oxidases, Elastic Fiber Homeostasis and Pseudoexfoliation Glaucoma
4:00 - 4:30 Don Zack, M.D., Ph.D.
Professor of Ophthalmology
Johns Hopkins University School of Medicine
Baltimore, MD
Retinal Ganglion Cell Neuroprotection: Is It a Viable Treatment Strategy for Glaucoma?
4:35 - 4.45 OVERVIEW AND CONCLUDING REMARKS
Paul Sieving, M.D., Ph.D.
Director, NEI, NIH, Bethesda, MD


Department of Health and Human Services NIH, the National Institutes of Health USA.gov